DOUBLE OUTLET RIGHT VENTRICLE
Clinical trials for DOUBLE OUTLET RIGHT VENTRICLE explained in plain language.
Never miss a new study
Get alerted when new DOUBLE OUTLET RIGHT VENTRICLE trials appear
Sign up with your email to follow new studies for DOUBLE OUTLET RIGHT VENTRICLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart surgery in first month of life may give babies with rare defect a better future
Disease control Recruiting nowThis study tests whether operating within the first 28 days of life (neonatal repair) is safer and more effective than waiting until 3-6 months (infant repair) for babies born with Tetralogy of Fallot, a serious heart defect. About 160 full-term newborns weighing over 2.5 kg will…
Matched conditions: DOUBLE OUTLET RIGHT VENTRICLE
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 17, 2026 13:04 UTC
-
Could a common heart drug spark new muscle growth in babies?
Disease control Recruiting nowThis early-phase trial tests whether the drug propranolol can stimulate new heart muscle cell growth in infants born with Tetralogy of Fallot, a serious heart defect. About 40 babies under 60 days old will receive the drug before routine surgery, and researchers will examine disc…
Matched conditions: DOUBLE OUTLET RIGHT VENTRICLE
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 17, 2026 12:45 UTC